AzTrials
AzTrials

Prone posıtıonNCT06493058

Extruded the effectıveness of Prone posıtıon ın ınfants evaluatıon

A study testing Prone positioning in people with Prone posıtıon, run by Istanbul Medipol University Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to determine the effect of prone position on vital signs, arterial blood gases and blood values in 0-1 year old infants extubated after congenital heart surgery. The study was a randomised controlled experimental type study. Read more about this study

Who is it for?
Ages 1 day to 1 yearHealthy volunteers can take part
Conditions the study is for
Prone posıtıon
What is being tested?
Prone positioning
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2021to 25 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 1 year
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • To be between 0-1 years old
  • Having congenital heart surgery
  • Endotracheal intubation has been applied
  • Being extubated after congenital heart surgery
  • Obtaining permission from their parents to participate in the study

Who cannot join

  • In addition to the diagnosis of congenital heart disease, congenital heart disease of the lungs with any of the anomalies,
  • Position that may affect cardiac, circulatory and respiratory functions or surgical intervention that prevents ECMO (open sternum bone, ECMO support, etc.)
  • Complications developed during the study,
  • Infants whose parents did not agree to participate in the study were included in the study. is not recognised.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Meidpol University Hospital

    Istanbul, Beykoz, 34815

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluatıon of the Effectiveness of the Prone Position in Babies Extubed After Congenital Cardio Surgery

The aim of this study was to determine the effect of prone position on vital signs, arterial blood gases and blood values in 0-1 year old infants extubated after congenital heart surgery. The study was a randomised controlled experimental type study.

Read the detailed description

The sample of the study consisted of 40 infants aged 0-1 year who underwent surgery in the Cardiovascular Surgery Intensive Care Unit of a private hospital.Data collection tools consisted of "Data Collection Form", "Vital Signs Follow-up Form", "Arterial Blood Gas Follow-up Form", "Blood Values Follow-up Form" prepared by the researcher in line with the literature information and some measurement data used in the study (arterial blood sample obtained with the blood gas measurement device used in the NICU and blood gas parameters (PaCO2, pH, PaO2, Lac and SaO2) and bedside monitor).

The study was conducted in the Cardiovascular Surgery Intensive Care Unit of a private foundation university hospital. Infants between the ages of 0 and 1 year who had undergone congenital heart surgery and were extubated after surgery, who did not have any congenital anomalies of the lungs in addition to congenital heart disease, who did not have any condition that could affect cardiac, circulatory and respiratory functions or prevent positioning were included in the study. The infants to be included in the study were randomly selected to the control and study groups to avoid bias in the study. Which of the experimental or control groups the infants included in the study would be in was determined by using the address "https://www.calculatorsoup.com".

Being tested
Prone positioning
Keywords
Congenital Heart Diseases, Extubation, Newborn, Prone Position
Medical subject headings
Heart Defects, Congenital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prone positioningOther

    The babies in the study group were given the supine, right lateral and left lateral positions (12×1), which are used in nursing care practices in the clinic after extubation, in addition to the supine, right lateral and left lateral positions (12×1), the prone position was given twice a day for 2×2 hours twice a day within 48 hours after extubation, with the head on the midline of the neck and the head facing to the right or left side.

Study groups in NCT06493058
Study groupRoleWhat they receive
Intervention groupExperimentalIn our study, the babies in the study group were given the supine, right lateral and left lateral positions (12×1), which are used in nursing care practices in the clinic after extubation, in addition to the supine, right lateral and left lateral positions (12×1), the prone position was given twice a day for 2×2 hours twice a day within 48 hours after extubation, with the head on the midline of the neck and the head facing to the right or left side.
Receives: Other: Prone positioning
Control groupNo interventionBabies in the control group did not receive any treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Life Findings Monitoring Form

    Pulse values were monitored for 48 hours

    Measured: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation

  2. Life Findings Monitoring Form

    Saturation values were monitored for 48 hours

    Measured: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation

  3. Life Findings Monitoring Form

    Blood pressure values were monitored for 48 hours

    Measured: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation

Secondary outcomes (6)
  1. Arterial Blood Gas Monitoring Form

    After positioning, potansiyel hidrojen in blood were evaluated.

    Measured: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation

  2. Arterial Blood Gas Monitoring Form

    After positioning, Partial arterial oxygen pressure, were evaluated.

    Measured: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation

  3. Arterial Blood Gas Monitoring Form

    After positioning, Partial arterial carbon dioxide pressure were evaluated.

    Measured: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation

  4. Arterial Blood Gas Monitoring Form

    After positioning, Arterial oxygen saturation were evaluated.

    Measured: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation

  5. Arterial Blood Gas Monitoring Form

    After positioning, Laktat, were evaluated.

    Measured: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation

  6. Arterial Blood Gas Monitoring Form

    After positioning, arterial blood gases were evaluated.

    Measured: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2024
  2. Study start1 Jul 2021
  3. Primary completion30 Mar 2022
  4. Study completion25 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06493058
Sponsor's protocol ID
E-10840098-772.02-3150
Status last verified
Jun 2024
First submitted
20 Apr 2024
Last updated
9 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Prone positioning in people with Prone posıtıon, run by Istanbul Medipol University Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Life Findings Monitoring Form (time frame: Taken immediately before extubation and at 8, 16, 24, 32 and 48 hours after extubation). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in